Amset

Quick links to important sections

Amset

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amset

Property Description
Active ingredient Amlodipine (typically as Amlodipine besilate)
Form Tablets, Oral Solution, or Oral Suspension
Pharmacological class Calcium Channel Blocker (Dihydropyridine)
Common use Management of high blood pressure and chronic chest pain
Origin Synthetic organic compound

What Type of Medicine is Amset (Amlodipine)?

Amset is a pharmaceutical product defined by its active ingredient, Amlodipine, which is chemically a synthetic organic compound and belongs to the Calcium Channel Blocker (CCB) pharmacological class. Amlodipine is specifically a dihydropyridine derivative, a type of calcium ion antagonist that selectively inhibits calcium influx into vascular cells. As a single-entity drug, Amset is typically formulated using the salt amlodipine besilate along with standard excipients appropriate for its oral administration.

The medication is included on the WHO Essential Medicines List, clinically recognized for its reliable efficacy and safety profile in managing core cardiovascular risks. For oral administration, Amset is available in standard tablets, but also in specialized formulations such as an oral solution and oral suspension (such as Norliqva or Katerzia preparations) to accommodate specific patient needs, including those in pediatric care.

What is the General Purpose of Taking Amset?

The general purpose of Amset is to help the body manage conditions that require the long-term relaxation and widening of arterial blood vessels. Its core function as a peripheral arterial vasodilator causes the vascular smooth muscle to relax, leading to a measurable reduction in peripheral vascular resistance and subsequently, a lowering of blood pressure. Research affirms that this mechanism offers substantial and sustained control over blood pressure throughout the day. This effect, which establishes the drug as an antihypertensive and anti-anginal agent, reduces the workload on the heart and is intended to sustain adequate blood and oxygen supply to the heart muscle, a crucial benefit for patients with hypertension or chronic stable angina.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Amset?

The possible adverse reactions associated with Amlodipine (Amset) are documented in official regulatory sources, often categorized by frequency and the body system affected. These classifications establish the expected safety profile of the medicine.

Commonly Documented Adverse Reactions

Adverse reactions classified as Very Common in regulatory documents include edema (swelling, often of the ankles or lower extremities). Reactions classified as Common include: headache, dizziness, somnolence, flushing, palpitations, abdominal pain, and nausea. These effects, which relate primarily to vascular and nervous system disorders, are sometimes reported with a greater frequency at the start of therapy.

Serious Adverse Reactions and Safety Constraints

Very Rare but clinically significant adverse reactions documented in official sources include myocardial infarction, arrhythmia, hepatitis, jaundice, pancreatitis, and severe skin reactions such as Stevens-Johnson Syndrome.

The medicine is contraindicated in patients with conditions such as severe hypotension and cardiogenic shock. Caution is specifically advised in individuals with hepatic impairment, as their drug clearance is documented to be decreased, resulting in higher systemic exposure. The official profile also notes that older adults exhibit reduced clearance compared to younger patients, requiring close safety monitoring.

Overdose and Emergency Response

Amset Overdose and when to seek help

The information below summarizes the officially documented descriptions of overdose for Amset (Amlodipine) and the corresponding regulator-mandated emergency actions.


Overdose Manifestations and Severe Outcomes

Overdose may lead to marked hypotension (severely low blood pressure) and excessive peripheral vasodilation, which can trigger a reflex tachycardia (rapid heart rate). Clinical signs may include dizziness or fainting (syncope). The severe, unmanaged presentation can escalate to vasogenic shock, carrying the official risk of multiple organ failure or death noted for severe Calcium Channel Blocker toxicity.

Required Emergency Actions

If overdose is suspected, immediate medical attention is required. Contact emergency services (e.g., 911) if the person has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened. The regulatory instruction is to initiate active cardiac and respiratory monitoring and provide cardiovascular support, including the use of vasopressors such as phenylephrine if hypotension is unresponsive to fluid administration.

Supportive Treatment Status

No specific antidote is known for Amlodipine overdose, and hemodialysis is not likely to be of benefit due to high protein binding. Treatment is symptomatic and supportive, often requiring an overnight hospital stay for continuous observation of hemodynamic stability.

Therapeutic Uses of Amset

What Amset Treats: Main Uses and Benefits

Amset (Amlodipine) is generally applied when appropriate for conditions marked by increased physiological stress, focusing on systemic stability and easing distressing symptomatic manifestations. Its primary therapeutic use is in addressing systemic high blood pressure (hypertension) in adults and pediatric patients aged 6 to 17 years, as well as providing supportive relief for recurrent ischemic chest discomfort (angina pectoris), including chronic stable and vasospastic types.

The core support provided by this medication helps address symptoms related to systemic imbalance. It is applied in contexts where additional support for symptomatic management is needed, and is relevant in clinical settings that involve acute or unstable symptom patterns.

“This therapeutic use contributes to improved comfort during periods of heightened symptoms by supporting the maintenance of stable pressure.”

For patients with documented Coronary Artery Disease, Amset is relevant in situations requiring long-term assistance in cardiovascular stabilization. The therapy is commonly used to help with symptomatic management that may assist with maintaining functional stability.


Quick Fact: Symptomatic Support for Anginal Discomfort

Amset is relevant for managing symptom clusters that may become intense or disruptive, and is applied in addressing symptoms related to organ-specific functional stress.

Eligibility and Restrictions for Use

Official Population Eligibility for Amset

Amset (Amlodipine) is authorized for use based on specific patient populations and pre-existing conditions as defined by regulatory labeling.

Populations for whom use is allowed (as stated in label):

  • Adult patients (18 years and older) for all labeled indications.
  • Pediatric patients aged 6 to 17 years for the treatment of hypertension only.

Populations for whom use is contraindicated: Amset is an absolute non-eligibility option for patients with known hypersensitivity or allergy to amlodipine. Use is also strictly contraindicated in specific cardiovascular conditions, including cardiogenic shock, severe hypotension, and significant obstruction of the outflow tract of the left ventricle (e.g., severe aortic stenosis).

Eligibility-Related Restrictions: Eligibility is conditional for populations with compromised drug clearance. Patients with severe hepatic impairment may be eligible, but a low initial dose is necessary due to reduced drug metabolism. A lower initial dose is similarly advised for elderly patients. The drug is not recommended for use in children under 6 years of age as safety and effectiveness have not been established.

Pregnancy and Lactation Status: Use during pregnancy is restricted to situations where the therapeutic benefit is determined to justify the potential risk, as human safety data are not established. Use is generally not recommended during breastfeeding as amlodipine is known to be excreted into human milk.

What should I know about interactions with other medicines?

Amset Interactions with other medicines and products

Amset (Amlodipine) interacts with other products primarily by altering drug concentrations in the body or by producing additive pharmacological effects, as documented in regulatory prescribing information.


Documented Pharmacokinetic Interactions

Amset is a substrate of the CYP3A4 enzyme and a weak inhibitor of this pathway, which is the basis for several official interaction statements:

  • CYP3A Inhibitors: Co-administration with strong and moderate CYP3A inhibitors (e.g., Azole Antifungals, Clarithromycin) leads to increased systemic exposure of Amlodipine.
  • CYP3A Inducers: Substances like Rifampicin and the herbal product St. John's wort (Hypericum perforatum) may reduce Amlodipine plasma concentrations and require monitoring.

Interactions Affecting Co-administered Drug Exposure

Co-administered Medicine Regulatory Restriction Rationale
Simvastatin Must be limited to 20 mg daily Amset significantly increases Simvastatin exposure.
Immunosuppressants Requires close monitoring and dose adjustment Amset may increase the exposure of Tacrolimus and Cyclosporine.

Pharmacodynamic and Product Interactions

  • Antihypertensive Agents: Concurrent use with other agents (e.g., beta-blockers) may result in an additive blood pressure lowering effect.
  • Grapefruit/Grapefruit Juice: Use is not recommended as it may increase Amlodipine bioavailability.
  • Dantrolene (Infusion): Co-administration must be avoided due to the risk of hyperkalemia.

The plasma elimination half-life of Amset is prolonged in patients with severe hepatic impairment, which necessitates consideration of the drug's metabolic interaction profile in this population.

Mechanism of Action

Targeted Blockade of Vascular Calcium Channels

Amlodipine works as a highly selective antagonist of the L-type Voltage-Dependent Calcium Channels ( Cav1.2) found predominantly on the cell membranes of peripheral arterial smooth muscle cells. By inhibiting the influx of calcium ions ( Ca^2+) into these cells, the molecule reduces the signal strength for muscle contraction, interrupting the Excitation-Contraction Coupling pathway.

Reduction of Arterial Smooth Muscle Tone

The consequence of blocking calcium influx is a reduced concentration of free Ca^2+ inside the smooth muscle cells, which prevents the full activation of the contractile machinery (myosin light chain kinase). This action results in the relaxation and widening (vasodilation) of the arterioles. This mechanism contributes to a reduction in Systemic Vascular Resistance (SVR) and the total resistance the heart must overcome.

⏳ Selective Action and Kinetic Constraint

The drug demonstrates a high degree of vascular selectivity, meaning its mechanism primarily modulates blood vessel tone, with less functional impact on the heart's contractile force or rhythm. Amlodipine's slow interaction kinetics at the channel contribute to the prolonged duration of the physiological change over a period.

Dosage and Administration Information

How to Use Amset

The administration of Amset, which contains amlodipine, is guided by a standardized protocol. Amset is approved for oral administration and is typically used as part of a long-term treatment plan for chronic conditions, such as high blood pressure and stable angina. The fundamental principle of use is a once-daily dosing schedule.


Official Dosing Regimens and Administration

The dosage schedule is tailored to the patient population, but is strictly defined by maximum and minimum established doses. For most adult patients, the initial starting dose is 5 mg once daily, with a standard maintenance range between 5 mg and 10 mg. The maximum recommended dose for adults is 10 mg per day.

Population Group Initial Dose Maximum Dose
Adults 5 mg once daily 10 mg once daily
Pediatrics (6–17 years) 2.5 mg once daily 5 mg once daily

Usage Logistics and Dose Adjustment

Amset can be taken with or without food, as its bioavailability is not significantly affected by meals. To ensure consistent drug levels, patients are directed to take the medicine at approximately the same time each day. When a dosage change is necessary, guidelines recommend a gradual titration interval of generally 7 to 14 days to fully assess the response before increasing the dose.

In specific patient scenarios, such as older adults or those with hepatic impairment, a lower starting dose of 2.5 mg once daily may be used. If a dose is missed, it is advised to take it as soon as it is remembered, unless it is close to the next scheduled dose; under no circumstances should the dose be doubled.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Amset (Amlodipine)

This overview summarizes the key clinical research used by regulators to evaluate Amset (Amlodipine). It describes the structure of the studies, the outcomes that were measured, and the recognized areas where research remains limited or uncertain. This information is intended to provide context on the evidence base and should not be used for self-diagnosis or making treatment decisions.


Evidence for Use in Managing High Blood Pressure (Hypertension)

Research examining Amlodipine for the management of high blood pressure is primarily derived from large-scale, long-term Randomized Controlled Trials (RCTs) and comprehensive systematic meta-analyses. These extensive studies were applied in research contexts involving the management of chronic high blood pressure.

Researchers studied a wide range of adults with essential high blood pressure. The major outcomes that were monitored included the measured change in Systolic and Diastolic Blood Pressure (BP) readings, along with the frequency of fatal and non-fatal cardiovascular events, such as stroke or heart attack, over follow-up periods of several years.

Studies reported measurements of changes in blood pressure readings that were largely consistent throughout the daily dosing interval. Large-scale outcome trials also described patterns in the frequency of serious cardiovascular events in the observed populations.


Evidence for Use in Managing Chronic Chest Pain (Angina Pectoris)

This part focuses on the studies that evaluated Amlodipine for chronic chest pain, describing the measured outcomes related to symptom control for both chronic stable angina and vasospastic angina.

For chronic stable angina, the evidence is based on short-term RCTs that evaluated adult patients. Outcomes monitored included the frequency of chest pain episodes and the need for nitroglycerin for relief, which are both outcomes related to physical discomfort. The trials described patterns in the measured symptomatic outcomes related to these conditions.

For vasospastic angina, controlled clinical trials were used to evaluate adult patients. Studies monitored the change in the number of vasospasm episodes and the management of associated chest pain.


What Research Gaps and Uncertainty Remain

Official reviews have documented specific areas where the research landscape has limitations:

  • Long-term effects are not fully established for the angina-related indications because follow-up durations were primarily focused on short-term symptomatic relief.
  • Data for certain groups remain insufficient, particularly concerning long-term outcomes in the pediatric population.
  • Regulatory bodies recognize that certain subgroup findings are uncertain, especially for individuals with documented Coronary Artery Disease (CAD) who also have reduced heart function, due to the exclusions in the landmark trials.

Key Studies & References

  1. Tolerability and effectiveness of (S)-amlodipine compared with racemic amlodipine in hypertension: a systematic review and meta-analysis

Frequently Asked Questions (FAQ)

Common questions about Amset (FAQ)


Q: How quickly should I expect to feel the effects of Amset?

A: Official information indicates that this medication is intended for long-term management and works to maintain consistent drug levels throughout the day. While the medication starts working after taking a dose, the full blood pressure lowering effect is typically assessed by a healthcare professional over 7 to 14 days following a dose adjustment. The medication's long-acting nature means its effects are gradual and sustained, not immediate.


Q: What happens when I stop taking Amset?

A: Discontinuing the medication may cause blood pressure to increase, potentially raising cardiovascular risk. Regulatory information based on clinical data suggests that blood pressure generally returns to its previous level over approximately one week after stopping the drug. Discussions about discontinuing treatment should be held with a healthcare provider.


Q: Can Amset cause weight gain or loss?

A: Weight changes, including both weight gain and weight loss, have been reported in clinical trials, although these are not listed as the most common side effects. Weight gain may sometimes be related to edema (swelling, often in the ankles or legs), which is a common side effect of the medication. The full list of reported adverse reactions is detailed in the official safety information section.


Q: Is Amset used for preventive care?

A: Yes, official regulatory documents include an indication for preventative use in certain patients. For people with angiographically documented Coronary Artery Disease (CAD) without heart failure, Amset is approved to help reduce the risk of hospitalization for angina and the need for a coronary revascularization procedure.


Q: Is it possible to develop a tolerance to Amset?

A: According to the official prescribing information, clinical studies have not demonstrated tolerance (a reduced response over time) to the blood pressure lowering effects in patients studied for up to one year. The medication is designed to provide sustained control over long periods of use.


Q: What kind of monitoring is needed when taking Amset long-term?

A: While taking Amset, patients should receive close safety monitoring and regular blood pressure checks. Official documents note that specific blood tests may be required if the medication is taken alongside certain other drugs, such as immunosuppressants, to monitor their drug levels in the blood.


Q: How long before a major surgery should I stop taking Amset?

A: Clinical guidance suggests that Amset should generally be continued for both elective and emergency surgery to help maintain blood pressure control and prevent angina. Clinical guidelines state the decision to continue or stop the medication is made by the surgical and prescribing team.


Q: Are there any restrictions on strenuous exercise while taking Amset?

A: Regulatory information and clinical data do not list specific restrictions on exercise while taking the medication. Since Amset primarily works on blood vessels, it does not typically affect heart rate or cardiac function during exercise in people with normal heart function.


Q: Is Amset known to affect sleep patterns?

A: Official information lists somnolence (drowsiness) as a possible common side effect. However, clinical studies have shown that the medication is effective at lowering blood pressure, including during sleep. Some studies have suggested the medication may modulate sleep quality in certain hypertensive patients.


Q: Why would a doctor choose Amset instead of a different medication for the same condition?

A: Official prescribing indications suggest the choice may be based on the medication’s proven ability to help reduce the risk of cardiovascular events, such as stroke and heart attack. It is also approved for use in managing both high blood pressure and chronic stable or vasospastic angina.


Q: Do I need to get regular blood tests while I'm on Amset?

A: While continuous blood pressure monitoring is essential, routine blood tests are generally not needed for everyone on Amset. Specific blood level tests are only required if you are also taking certain other medications, such as immunosuppressants, which can interact with Amset.


Q: Can Amset make existing conditions worse?

A: Official warnings note that in some patients, especially those with severe obstructive coronary artery disease, starting or increasing the dosage of Amset could potentially lead to an increase in the frequency or severity of angina, or in very rare cases, an acute heart attack.


Q: Is it okay to take herbal supplements while on Amset?

A: One specific herbal product, St. John's wort (Hypericum perforatum), is mentioned in official interaction documents. This supplement may reduce the levels of Amset in your blood, and close monitoring would be required. Patients are advised to disclose the use of any supplements to their healthcare provider due to potential interactions.


Q: Why are there different strengths or dosages of Amset available?

A: Different tablet strengths are available to allow for flexible adjustment of the treatment to meet individual blood pressure goals. They also help accommodate special patient populations, such as elderly patients or those with liver impairment, who may require a lower starting dose.


Q: What happens if I accidentally miss a dose of Amset?

A: The official instructions advise taking a missed dose as soon as it is remembered, unless it is close to the next scheduled dose, in which case the missed dose should be skipped. Official administration instructions state that the dose should not be doubled to compensate for a missed dose.


Q: Can Amset make you feel drowsy or tired during the day?

A: Yes, official safety information lists somnolence (drowsiness) as a possible common side effect of the medication. This effect, along with dizziness, may be more noticeable when treatment is first started.


Q: Are there any specific foods I should avoid while on Amset?

A: Official interaction documents specifically recommend avoiding grapefruit and grapefruit juice as they may increase the amount of the medication in your body. There are no other specific food restrictions listed.


Q: Can Amset affect my ability to drive or operate machinery?

A: Because common side effects like dizziness and drowsiness (somnolence) can occur, official information advises caution. If these side effects are experienced, the ability to drive or operate machinery may be impaired.


Q: What should I do if the side effects from Amset don't go away after a week?

A: Official information states that common side effects, such as headache and swelling, are sometimes reported with greater frequency when treatment is initiated. If side effects persist or become bothersome, seeking guidance from a healthcare professional is appropriate.


Q: Does Amset interact with common over-the-counter cold and flu medicine?

A: While the medication interacts with some strong enzymes in the body (CYP3A4), common over-the-counter cold and flu medicines are generally not specifically listed in regulatory documents as requiring a dose adjustment for Amset. Patients should consult a healthcare provider or pharmacist regarding the co-administration of any other medication.


Q: Can Amset interfere with birth control pills?

A: Official regulatory documents and safety data do not specifically mention any known interaction or interference between Amset and oral contraceptive pills.


Q: Why do some people report feeling no change after starting Amset?

A: The medication is intended for a gradual and sustained effect, and the response is officially assessed over a 7 to 14 day titration interval. Since the primary goal is to lower blood pressure, which often has no noticeable symptoms, feeling 'no change' may indicate the medication is working subtly as intended.


Q: Does the effectiveness of Amset change over time?

A: Studies have confirmed that the medication offers sustained and measurable control over blood pressure throughout the daily dosing interval and over long periods. Official regulatory sources have not demonstrated a loss of effectiveness (tolerance) over at least one year of use.

How should Amset be stored and disposed of?

How to Store and Dispose of Amset (Amlodipine)

Official labeling mandates specific conditions to ensure product integrity and safety. Amset tablets must be stored at Controlled Room Temperature (between 15 C and 30 C / 59 F and 86 F). The medication must be protected from light and kept away from excessive heat and moisture, with an explicit rule to keep it from freezing.

Storage and Handling Requirements

Condition Requirement
Temperature Controlled Room Temperature, Avoid Freezing
Protection Keep away from heat, moisture, and direct light
Packaging Store in a tightly closed, light-resistant container
Safety Always keep out of the sight and reach of children

For disposal, unused or expired Amset should not be flushed down the toilet or washed down the sink due to environmental concerns. The officially preferred method for discarding is by using an authorized drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Amset found in:

A-Z Index: